Navigation Links
CTMM Becomes One of the World's Largest Public-Private Partnerships in Translational Medical Research
Date:8/4/2009

EINDHOVEN, The Netherlands, August 4 /PRNewswire/ -- With today's final approval of a research project into prostate cancer, the Dutch CTMM (Center for Translational Molecular Medicine) today announced the successful completion of 265 million euro funding for translational (bench-to-bedside) medical research, making CTMM one of the largest public-private partnerships in the world. This pivotal point in the organisation's development firmly positions the Netherlands as one of the world's leading destinations for translational biomedical research.

"The 15 million euro allocated to this prostate cancer project, which brings the total allocated CTMM funding to 265 million euro, should enable the project team to make a real difference to the diagnosis and treatment of a disease that counts among the biggest killers of men," said Peter Luijten, CTMM Chief Scientific Officer.

With this final project approval, CTMM has fulfilled the initial objectives of its business plan by establishing public-private research consortia to address the world's most prevalent diseases. The CTMM project portfolio now comprises 18 projects conducting translational molecular medicine research into innovative new techniques for the diagnosis and treatment of cancer, cardiovascular, neurodegenerative and infectious/auto-immune disease. In total, more than 100 partners from industry and academia are involved in the projects, which are funded on the basis of 25% from industry, 25% from academia and 50% from the Dutch government.

About CTMM

CTMM (Center for Translational Molecular Medicine) is a Netherlands-based public-private partnership dedicated to the development of technologies in molecular medicine that enable early diagnosis and personalised treatment for oncology, cardiovascular, neurodegenerative and infectious/auto-immune disease - the four main areas of disease causing mortality and diminished qua
'/>"/>

SOURCE CTMM
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. The Ocean Becomes a Pipeline To A Cure for Cystic Fibrosis
2. Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen-Deprivation Therapy
3. Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and Performance
4. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
5. PSA Screening Cuts Deaths by 20%, Says Worlds Largest Prostate Cancer Study
6. Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer
7. Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
8. Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
9. The Largest Ever Study of Diabetes Shows Intensive Glucose Control Reduces Serious Complications
10. Safety and Efficacy Results Presented From Largest Prospective Controlled Clinical Study of Ulcerative Colitis
11. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 23, 2014 Tianyin Pharmaceutical Co., ... specializes in patented biopharmaceutical, modernized traditional Chinese medicine ... today announced that the Company achieved the Public ... Practice (GMP) certificate of TPI,s Qionglai Facility (QLF) ... The public notice period is a significant procedure ...
(Date:12/22/2014)... NxStage Medical, Inc. (NASDAQ: NXTM ... announced today that the U.S. Food and Drug ... perform hemodialysis overnight while the patient is at ... System One is the first and only hemodialysis ... Home nocturnal hemodialysis is an ...
(Date:12/22/2014)... , Dec. 22, 2014  ConvaTec, a privately-held ... Moraviec has been appointed Interim Chief Executive Officer of ... Moraviec succeeds Ken Berger .  "The Board of ... in leading ConvaTec over the past three years," said ... of Directors.  "We are confident that the company is ...
Breaking Medicine Technology:TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2
... Oct. 18, 2011 Octapharma USA ... over the next few months, including AABB,s 64th Annual ... 25 and National Hemophilia Foundation,s (NHF) 63rd Annual Meeting ... In December, Octapharma USA will also participate in the ...
... Oct. 18, 2011 For thousands of nurses, lab technicians, ... of shopping for the latest in scrub fashions that are ... on the success of the 10 original stores that launched ... to open in Tampa, Orlando and Miami FL; Rochester and ...
Cached Medicine Technology:Octapharma USA to Participate in Important Medical Meetings at AABB, NHF, ASHP and ASH 2Octapharma USA to Participate in Important Medical Meetings at AABB, NHF, ASHP and ASH 3Octapharma USA to Participate in Important Medical Meetings at AABB, NHF, ASHP and ASH 4An RX for Busy Healthcare Professionals 2An RX for Busy Healthcare Professionals 3
(Date:12/26/2014)... DW-InductionHeating.com (DaWei Induction Heating Co.) is a comprehensive ... and marketing of a series of induction heating equipment. ... series of induction brazing equipments . , According ... brazing refers to the joining of two or ... The manager says that there are fundamental differences in ...
(Date:12/25/2014)... The report “Nintedanib (Colorectal Cancer) ... on the current treatment landscape, unmet needs, current ... market. Stivarga is a drug which is used ... Boehringer Ingelheim is developing nintedanib (BIBF-1120), an orally ... CRC in the US, Europe, and Japan. The ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 Recently, Dylan ... dresses, has excitedly released its collection of discounted prom ... to Percy, a senior spokesman of the company, the ... of this promotion is to expand the UK market. ... in several different colors, lengths, and styles: A-line strapless, ...
(Date:12/25/2014)... When head lice hits a home or school, parents and ... of it while keeping it from taking over the house ... solution right in their neighborhood: Lice Troopers . Expanding ... spectrum head lice screening and treatment services to families and ... Brickell, Coconut Grove, Kendall, Pinecrest and South Miami. , The ...
(Date:12/25/2014)... early stage breast cancer patients who undergo chemotherapy and/or ... eventually develop leukemia as a result of their treatment, ... a review of more than 20,000 breast cancer cases ... the risk for developing treatment-related leukemia, though low, is ... frequency of bone marrow cancers such as leukemia is ...
Breaking Medicine News(10 mins):Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3
... , , , HATBORO, Pa., ... a leading technology provider of enterprise mobility solutions for the healthcare ... panel discussion as part of Mobile Monday Mid-Atlantic, Monday September 21, ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20090618/NE35135LOGO ) ...
... , , , ... NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic ... financing with institutional and other accredited investors, including members of ... half of the offering. Gross proceeds of approximately $2.9 million ...
... HLTH Corporation (Nasdaq: HLTH ) today announced that ... segment to affiliates of Aurora Capital Group, a Los Angeles based ... the fourth quarter and is subject to customary closing conditions, including ... Act. , , The purchase price of ...
... Sept. 18 NBTY, Inc. (NYSE: NTY ) ( ... today announced that it will web cast presentations by Harvey Kamil, President ... , , Mr. Kamil,s presentation at the ... 2009 will be web cast at 4:30 PM Eastern Time that day. ...
... , , CLEVELAND, Sept. ... 45-minute seminar that highlights the critical need for long-term care insurance ... available. It will be held at multiple times in 4 Ohio ... , , *(PHOTO 72dpi: Send2Press.com/mediaboom/09-0910-3in4ltc_72dpi.jpg) ...
... , , , ... www.maxhealthcare.in ) and Perot Systems Corporation (NYSE: PER ... which Perot Systems will provide IT outsourcing (ITO) and electronic health records ... in the Indian healthcare industry as well as the company,s first India-based ...
Cached Medicine News:Health News:InfoLogix to Present 'Mobile in the Enterprise: Keeping up with User Demand While Containing Costs' at Mobile Monday Panel in Philadelphia 2Health News:InfoLogix to Present 'Mobile in the Enterprise: Keeping up with User Demand While Containing Costs' at Mobile Monday Panel in Philadelphia 3Health News:NewCardio Completes $2.9 Million Private Placement 2Health News:NewCardio Completes $2.9 Million Private Placement 3Health News:NewCardio Completes $2.9 Million Private Placement 4Health News:HLTH Corporation Announces Agreement to Sell Porex Unit to Aurora Capital Group for $142 Million 2Health News:HLTH Corporation Announces Agreement to Sell Porex Unit to Aurora Capital Group for $142 Million 3Health News:NBTY to Web Cast Presentations at UBS Global Life Sciences Conference and Canaccord Adams Healthy Living Conference 2Health News:NBTY to Web Cast Presentations at UBS Global Life Sciences Conference and Canaccord Adams Healthy Living Conference 3Health News:Long Term Care Seminars in Dayton, Cleveland, Cincinnati, and Columbus -- Free to Public 2Health News:Long Term Care Seminars in Dayton, Cleveland, Cincinnati, and Columbus -- Free to Public 3Health News:Max Healthcare of India Selects Perot Systems for Over Rs. 90 Crores ($18 Million) 10-year IT Services and Electronic Health Records Implementation 2Health News:Max Healthcare of India Selects Perot Systems for Over Rs. 90 Crores ($18 Million) 10-year IT Services and Electronic Health Records Implementation 3Health News:Max Healthcare of India Selects Perot Systems for Over Rs. 90 Crores ($18 Million) 10-year IT Services and Electronic Health Records Implementation 4Health News:Max Healthcare of India Selects Perot Systems for Over Rs. 90 Crores ($18 Million) 10-year IT Services and Electronic Health Records Implementation 5
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: